BOSUTINIB vs BREXPIPRAZOLE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
BOSUTINIB vs BREXPIPRAZOLE: Safety Overview
| Metric | BOSUTINIB | BREXPIPRAZOLE |
|---|---|---|
| Total FAERS Reports | 7,777 | 13,270 |
| Deaths Reported | 680 | 673 |
| Death Rate | 8.7% | 5.1% |
| Hospitalizations | 1,675 | 1,269 |
| Average Patient Age | 64.7 yrs | 50.5 yrs |
| % Female Patients | 51.8% | 69.0% |
| FDA Approval Date | May 23, 2025 | Aug 11, 2022 |
| Manufacturer | U.S. Pharmaceuticals | Otsuka America Pharmaceutical, Inc. |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |